1. Chichmanian RM, Heudier P, et al (1995) No cross hypersensitivity between molgramostim and filgastime: a propos of a case. Therapie 50:478–479
2. Forman AD (1994) Neurologic complications of cytokine therapy. Oncology 8:105–110
3. Illowsky Karp B, Jang JC, et al (1996) Multiple cerebral lesions complicating therapy with interleukin-2. Neurology 47:417–424
4. Ippoliti C, Przepiorkaba]D, et al (1993) Adverse effects of molgamostim in bone marrow transplant recipients. Clin Pharm 12:520–525